Schall Firm Logo 2.jpg
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09 janv. 2019 08h40 HE | Schall Law
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
01 janv. 2019 13h01 HE | Schall Law
LOS ANGELES, Jan. 01, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
EARLY JANUARY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
26 déc. 2018 08h30 HE | Schall Law
LOS ANGELES, Dec. 26, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
18 déc. 2018 12h20 HE | Schall Law
LOS ANGELES, Dec. 18, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
11 déc. 2018 16h21 HE | Schall Law
LOS ANGELES, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
06 déc. 2018 11h48 HE | Schall Law
LOS ANGELES, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
27 nov. 2018 11h11 HE | Schall Law
LOS ANGELES, Nov. 27, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
Schall Firm Logo 2.jpg
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
21 nov. 2018 12h47 HE | Schall Law
LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or...
TESARO® logo_RGB_small.png
TESARO Announces Second-Quarter 2018 Operating Results
02 août 2018 16h05 HE | TESARO, Inc.
ZEJULA® Q2 net sales totaled $54 million compared to $26 million for Q2 2017QUADRA sNDA submission planned for Q4 2018PRIMA Phase 3 ZEJULA monotherapy trial in first-line ovarian cancer regardless of...
TESARO® logo_RGB_small.png
TESARO Announces First-Quarter 2018 Operating Results
03 mai 2018 16h05 HE | TESARO, Inc.
ZEJULA Q1 net sales totaled $49 millionEnrollment completed in Phase 3 PRIMA first-line ovarian cancer monotherapy trial TOPACIO platinum-resistant ovarian cancer and triple-negative breast cancer...